Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 1/20 | 0.51 |
| ▸ | CD69 | Q07108 | 1/20 | 0.51 |
| ▸ | TLR4 | O00206 | 4/20 | 0.51 |
| ▸ | CD14 | P08571 | 4/20 | 0.51 |
| ▸ | LY96 | Q9Y6Y9 | 4/20 | 0.51 |
| ▸ | PTPRC | P08575 | 4/20 | 0.43 |
| ▸ | PTPN2 | P17706 | 4/20 | 0.43 |
| ▸ | PTPN1 | P18031 | 4/20 | 0.43 |
| ▸ | PTPRB | P23467 | 4/20 | 0.43 |
| ▸ | PTPN11 | Q06124 | 4/20 | 0.43 |
| ▸ | GSTA1 | P08263 | 6/20 | 0.37 |
| ▸ | GSTP1 | P09211 | 6/20 | 0.37 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14617494 | 0.84 | PTPRC (0.57) | ELANECD69TLR4CD14LY96 | |
| SCHEMBL14617492 | 0.82 | TLR4 (0.57) | ELANECD69TLR4CD14LY96 | |
| SCHEMBL16545609 | 0.79 | TLR4 (0.53) | ELANECD69TLR4CD14LY96 | |
| SCHEMBL13620669 | 0.76 | GABRA1 (0.50) | ELANECD69TLR4CD14LY96 | |
| SCHEMBL29517201 | 0.76 | GABRA1 (0.50) | ELANECD69TLR4CD14LY96 | |
| SCHEMBL9910710 | 0.76 | GABRA1 (0.50) | ELANECD69TLR4CD14LY96 | |
| SCHEMBL29945572 | 0.76 | GABRA1 (0.50) | ELANECD69TLR4CD14LY96 | |
| SCHEMBL2471228 | 0.76 | GABRA1 (0.50) | ELANECD69TLR4CD14LY96 | |
| SCHEMBL30547266 | 0.76 | GABRA1 (0.50) | ELANECD69TLR4CD14LY96 | |
| SCHEMBL8955766 | 0.75 | CD69 (0.52) | ELANECD69TLR4CD14LY96 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250389689-A1 | MICROFLUIDIC SENSOR FOR BACTERIA DETECTION IN BIOFLUIDS | UNIVERSITY OF MARYLAND, BALTIMORE COUNTY | 2025-12-25 | — | — | US | disclosed |
| EP-4172608-A1 | METHOD OF FORMING AN IONIC SENSOR AND CORRESPONDING APPARATUS | Technische Universität München (DE) | 2023-05-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250389689-A1 | MICROFLUIDIC SENSOR FOR BACTERIA DETECTION IN BIOFLUIDS | KLK3, STUB1, CLPP | ELANE 3195/4885CD69 222/4885TLR4 318/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.